Cardiovascular Disease

>

Latest News

Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose / image credit: ©New Africa/AdobeStock
Investigational Drug Reduces Lp(a) in High-Risk Adults: Daily Dose

December 4th 2024

Your daily dose of the clinical news you may have missed.

GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose / image credit: ©New Africa/AdobeStock
GLP-1RAs, SGLT2is Cut Risk of Future MI, Stroke in Survivors: Daily Dose

November 25th 2024

Among Stroke Survivors, GLP-1RAs, SGLT2is May Reduce Risk of Future MI, Recurrent Stroke / image credit American Heart Association
Among Stroke Survivors, GLP-1RAs, SGLT2is May Reduce Risk of Future MI, Recurrent Stroke

November 11th 2024

COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types
COVID-19 Linked to Long-Term Risk of MACE, Especially Among Adults with non-O Blood Types

October 9th 2024

Progression of Subclinical Atherosclerosis Independently Predicts All-Cause Mortality / image credit - plaque: ©Tefi/stock.adobe.com
Progression of Subclinical Atherosclerosis Independently Predicts All-Cause Mortality

October 2nd 2024

More News

© 2024 MJH Life Sciences

All rights reserved.